Pier Federico Gherardini

Systemic Immunity Is Required for Effective Cancer Immunotherapy

Matthew H. Spitzer, Yaron Carmi, Nathan E. Reticker-Flynn et al. · Cell · 2017 · 944 citations · Full text

Systemic Immunity, Tumor Immunology, Cancer Immunosurveillance +6

Highly multiplexed simultaneous detection of RNAs and proteins in single cells

Andreas P. Frei, Felice-Alessio Bava, Eli R. Zunder et al. · Nature Methods · 2016 · 331 citations

Bioinformatics, Simultaneous Detection, Single Cell Sequencing +9

High response rate to PD-1 blockade in desmoplastic melanomas

Zeynep Eroglu, Jesse M. Zaretsky, Siwen Hu‐Lieskovan et al. · Nature · 2018 · 326 citations · Full text

Melanoma, High Response Rate, Immune Checkpoint Inhibitor +4

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Lacey Padrón, Deena M. Maurer, Mark H. O’Hara et al. · Nature Medicine · 2022 · 316 citations · Full text

Randomized Phase 2, Pancreatic Cancer, Gastrointestinal Oncology +13

Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells

Bertram Bengsch, Takuya Ohtani, Omar Khan et al. · Immunity · 2018 · 306 citations · Full text

Epigenomic-guided Mass Cytometry, Cancer Immunosurveillance, Autoimmune Disease +12